These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38406039)

  • 1. A Case of Pneumocystis Pneumonia Developed During Rheumatoid Arthritis Treatment With Methotrexate and Golimumab.
    Yanagihara T; Oka Y; Moriwaki A; Moriuchi Y; Ogata H; Ishimatsu A; Otsuka J; Taguchi K; Yoshida M
    Cureus; 2024 Jan; 16(1):e52944. PubMed ID: 38406039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute exacerbation of interstitial pneumonia associated with rheumatoid arthritis during the course of treatment for Pneumocystis jirovecii pneumonia: a case report.
    Kuroda T; Takeuchi H; Nozawa Y; Sato H; Nakatsue T; Wada Y; Moriyama H; Nakano M; Narita I
    BMC Res Notes; 2016 Apr; 9():240. PubMed ID: 27113212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and radiological features of Pneumocystis pneumonia in patients with rheumatoid arthritis, in comparison with methotrexate pneumonitis and Pneumocystis pneumonia in acquired immunodeficiency syndrome: a multicenter study.
    Tokuda H; Sakai F; Yamada H; Johkoh T; Imamura A; Dohi M; Hirakata M; Yamada T; Kamatani N; Kikuchi Y; Sugii S; Takeuchi T; Tateda K; Goto H
    Intern Med; 2008; 47(10):915-23. PubMed ID: 18480575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pneumocystis pneumonia developed in two patients with rheumatoid arthritis during treatment of adalimumab].
    Ikeuchi H; Umemoto A; Tsukida M; Sakurai N; Maeshima A; Kuroiwa T; Hiromura K; Nojima Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(5):420-5. PubMed ID: 22041430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Soluble Interleukin-2 Receptor Is a Biomarker for Pneumocystis jirovecii Pneumonia among Patients with Rheumatoid Arthritis under Methotrexate Therapy.
    Sakamoto N; Hara S; Ishimoto H; Nakashima S; Yura H; Miyamura T; Okuno D; Hara A; Kakugawa T; Yamaguchi H; Obase Y; Kushima H; Ishii H; Noguchi S; Kido T; Kobayashi T; Soejima Y; Yoshioka S; Ishimatsu Y; Yatera K; Kadota JI; Mukae H
    Tohoku J Exp Med; 2019 Jul; 248(3):209-216. PubMed ID: 31366819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of sulfasalazine for the prevention of Pneumocystis pneumonia in patients with rheumatoid arthritis: A multicentric self-controlled case series study.
    Nunokawa T; Chinen N; Shimada K; Kimura M; Tateishi M; Chen FY; Setoguchi K; Sugihara M
    J Infect Chemother; 2023 Feb; 29(2):193-197. PubMed ID: 36334836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and radiological features of acute-onset diffuse interstitial lung diseases in patients with rheumatoid arthritis receiving treatment with biological agents: importance of Pneumocystis pneumonia in Japan revealed by a multicenter study.
    Kameda H; Tokuda H; Sakai F; Johkoh T; Mori S; Yoshida Y; Takayanagi N; Taki H; Hasegawa Y; Hatta K; Yamanaka H; Dohi M; Hashimoto S; Yamada H; Kawai S; Takeuchi T; Tateda K; Goto H
    Intern Med; 2011; 50(4):305-13. PubMed ID: 21325762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in clinical Pneumocystis pneumonia in rheumatoid arthritis and other connective tissue diseases suggesting a rheumatoid-specific interstitial lung injury spectrum.
    Shimada K; Yokosuka K; Nunokawa T; Sugii S
    Clin Rheumatol; 2018 Aug; 37(8):2269-2274. PubMed ID: 29876690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of rheumatoid arthritis complicated with methotrexate-induced pneumonitis and pneumocystis pneumonia].
    Minagawa S; Takayanagi N; Hara K; Takaku Y; Tsutiya Y; Hijikata N; Yamaji T; Tokunaga D; Saito H; Ubukata M; Kurashima K; Yanagisawa T; Sugita Y; Kawabata Y
    Nihon Kokyuki Gakkai Zasshi; 2008 Mar; 46(3):237-42. PubMed ID: 18409573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deterioration of the immune response induced by sulfamethoxazole-trimethoprim in a rheumatoid arthritis patient with Pneumocystis jirovecii pneumonia.
    Gochi M; Takayanagi N; Ishiguro T; Miyahara Y; Yanagisawa T; Shimizu Y; Sugita Y
    Intern Med; 2014; 53(11):1137-41. PubMed ID: 24881737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Reconstitution Inflammatory Syndrome-like Condition Associated with Pneumocystis jirovecii Pneumonia During Folinic Acid Treatment in a Rheumatoid Arthritis Patient.
    Arakawa N; Eguchi K; Nakamura Y; Tsukahara Y; Koushima Y; Matsushima H
    Intern Med; 2021 Oct; 60(19):3143-3147. PubMed ID: 33840694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Associated with Pneumocystis jirovecii Pneumonia in Patients with Rheumatoid Arthritis Receiving Methotrexate: A Single-center Retrospective Study.
    Ohmura SI; Homma Y; Masui T; Miyamoto T
    Intern Med; 2022 Apr; 61(7):997-1006. PubMed ID: 34511571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumocystis jirovecii Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis Recommendations.
    Mori S; Sugimoto M
    Clin Med Insights Circ Respir Pulm Med; 2015; 9(Suppl 1):29-40. PubMed ID: 26396551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Factors for Pneumocystis jirovecii Pneumonia in Patients With Rheumatoid Arthritis and a Prophylactic Indication of Trimethoprim/Sulfamethoxazole.
    Yukawa K; Nagamoto Y; Watanabe H; Funaki M; Iwahashi M; Yamana J; Sasaki R; Yamana S
    J Clin Rheumatol; 2018 Oct; 24(7):355-360. PubMed ID: 29664819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pneumocystis carinii pneumonia associated with low dose methotrexate treatment for malignant rheumatoid arthritis].
    Okuda Y; Oyama T; Oyama H; Miyamoto T; Takasugi K
    Ryumachi; 1995 Aug; 35(4):699-704. PubMed ID: 7482069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Rare Case of Pneumocystis Pneumonia in HIV Patient on Glucocorticoid.
    Rehman U; Farhan K; Shahnawaz W; Khalid MZ; Neupane K
    Cureus; 2021 Apr; 13(4):e14445. PubMed ID: 34079652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumocystis jiroveci pneumonia in patients with rheumatoid arthritis treated with infliximab: a retrospective review and case-control study of 21 patients.
    Komano Y; Harigai M; Koike R; Sugiyama H; Ogawa J; Saito K; Sekiguchi N; Inoo M; Onishi I; Ohashi H; Amamoto F; Miyata M; Ohtsubo H; Hiramatsu K; Iwamoto M; Minota S; Matsuoka N; Kageyama G; Imaizumi K; Tokuda H; Okochi Y; Kudo K; Tanaka Y; Takeuchi T; Miyasaka N
    Arthritis Rheum; 2009 Mar; 61(3):305-12. PubMed ID: 19248121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymptomatic carriage of Pneumocystis jiroveci in elderly patients with rheumatoid arthritis in Japan: a possible association between colonization and development of Pneumocystis jiroveci pneumonia during low-dose MTX therapy.
    Mori S; Cho I; Ichiyasu H; Sugimoto M
    Mod Rheumatol; 2008; 18(3):240-6. PubMed ID: 18306977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal perforation due to concomitant cytomegalovirus infection during treatment for Pneumocystis jirovecii pneumonia in a patient with rheumatoid arthritis.
    Ishiguro T; Takayanagi N; Kawabata Y; Sugita Y
    Intern Med; 2011; 50(17):1835-7. PubMed ID: 21881284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and risk factors for Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis receiving adalimumab: a retrospective review and case-control study of 17 patients.
    Watanabe K; Sakai R; Koike R; Sakai F; Sugiyama H; Tanaka M; Komano Y; Akiyama Y; Mimura T; Kaneko M; Tokuda H; Iso T; Motegi M; Ikeda K; Nakajima H; Taki H; Kubota T; Kodama H; Sugii S; Kuroiwa T; Nawata Y; Shiozawa K; Ogata A; Sawada S; Matsukawa Y; Okazaki T; Mukai M; Iwahashi M; Saito K; Tanaka Y; Nanki T; Miyasaka N; Harigai M
    Mod Rheumatol; 2013 Nov; 23(6):1085-93. PubMed ID: 23212592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.